Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
NCT04434846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-04-26
Summary
Background:
Zika, dengue, and chikungunya are spread by mosquitos. These diseases have a major impact on public health. This is especially true in in Southeast Asia. Non-human primates (such as macaques) could play an essential role in spreading these diseases. Researchers want to further understand the relationship between humans and these primates. They want to see how this affects how mosquito-borne viruses are spread in Southeast Asia.
Objective:
To describe the prevalence of Zika virus, dengue virus, and chikungunya virus in the blood of people who live close to long-tailed macaques in Thailand and Cambodia.
Eligibility:
Healthy people aged 18-55 who have lived or worked within approximately 10 kilometers of the Wat Amphae Phnom monkey habitat in Kampong Speu, Cambodia, for a minimum of 2 years
Design:
Participation will last 1 day.
Participants will be screened in person through an interview. Their medical history will be reviewed.
Participants will give information about themselves. This will include sex, age, and behaviors related to the spread of mosquito-borne disease. For example, they will be asked about the number of water containers at their home. They will be asked about recent travel. They will be asked about the extent of their contact with the macaques.
Participants will give a blood sample....
Conditions
- Dengue Fever
- Zika
- Vector-Borne Diseases
- Chikungunya
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Christina Yek, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-08
- Primary Completion
- 2021-05-07
- Completion
- 2021-05-07
Countries
- Cambodia
Study Locations
More Related Trials
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN
-
Applying Wolbachia to Eliminate Dengue
NCT03055585 ·Status: TERMINATED ·Phase: NA
-
Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
NCT03106714 ·Status: COMPLETED
-
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
NCT06268691 ·Status: COMPLETED ·Phase: NA
-
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
NCT03631719 ·Status: COMPLETED
-
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
NCT07094724 ·Status: RECRUITING ·Phase: PHASE2
-
Cohort of Patients Infected by an Arbovirus
NCT01099852 ·Status: UNKNOWN
-
Implementation Research of New Dengue Vector Control Tools
NCT00883441 ·Status: COMPLETED ·Phase: NA
-
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
NCT03641339 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults
NCT07257965 ·Status: RECRUITING ·Phase: NA
-
Sero-epidemiology of Priority Arboviruses in French Guiana
NCT03210363 ·Status: COMPLETED ·Phase: NA
-
Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale
NCT06595745 ·Status: TERMINATED ·Phase: NA
-
Impact of Project Wolbachia - Singapore on Dengue Incidence
NCT05505682 ·Status: COMPLETED ·Phase: NA
-
Reproducibility of Malaria Challenge in Healthy Volunteers
NCT01058226 ·Status: COMPLETED ·Phase: PHASE1
-
Characterizing Humoral Immune Response to Mosquito Bites
NCT04478370 ·Status: COMPLETED ·Phase: NA
-
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
NCT01254422 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
NCT00414336 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Responses After Human Subject Challenge With Sand Fly Bites
NCT01289977 ·Status: COMPLETED
-
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
NCT02406729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults
NCT02658253 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
NCT02334462 ·Status: COMPLETED ·Phase: PHASE1
-
Spatial Repellents for Aedes-borne Virus Control in Sri Lanka
NCT05452447 ·Status: COMPLETED ·Phase: NA
-
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
NCT06859619 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Experimental Vaccine for Plasmodium Falciparum Malaria
NCT00340431 ·Status: COMPLETED ·Phase: PHASE1
-
Vivax Malaria Human Infection Studies in Thailand
NCT04083508 ·Status: RECRUITING ·Phase: NA